Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

RETRACTED ARTICLE: MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition

  • Research Article
  • Published:
Tumor Biology

This article was retracted on 20 April 2017

Abstract

We have recently shown that Nrdp1 inhibits phosphorylation of ErB3 in colorectal cancer (CRC) cells, to suppress epidermal growth factor receptor (EGFR) signaling-stimulated MMP7 activation for CRC metastasis. In this study, we examined the control of Nrdp1 in CRC cells. We detected significant increases in miR-497 in CRC specimen, compared to paired normal colorectal tissue. Moreover, we detected a strong positive correlation between miR-497 levels and Nrdp1 levels, and a strong inverse correlation between miR-497 levels and MMP7 levels. In vitro, overexpression of miR-497 in human CRC cells significantly decreased Nrdp1 transcripts and protein, and vice versa. Moreover, overexpression of miR-497 in human CRC cells also significantly increased MMP7 transcripts, cellular protein, and secreted protein, resulting in increases in cell invasiveness in a transwell cell migration assay. Furthermore, we found that MiR-497 directly targeted 3′-UTR of Nrdp1 mRNA to inhibit its translation. Together, our data suggest that the regulation of MMP7 by Nrdp1 in CRC cells could be inhibited by miR-497 through suppressing Nrdp1 translation. Our work thus highlights a novel molecular regulatory machinery that regulates metastasis of CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. East JE, Dekker E. Colorectal cancer diagnosis in 2012: A new focus for crc prevention–more serration, less inflammation. Nat Rev Gastroenterol Hepatol. 2013;10:69–70.

    Article  PubMed  Google Scholar 

  2. Van Schaeybroeck S, Allen WL, Turkington RC, Johnston PG. Implementing prognostic and predictive biomarkers in crc clinical trials. Nat Rev Clin Oncol. 2011;8:222–32.

    Article  PubMed  Google Scholar 

  3. Labianca R, Beretta GD, Mosconi S, Pessi MA, Milesi L. The development of clinical research in crc. Ann Oncol. 2005;16 Suppl 4:iv37–43.

    PubMed  Google Scholar 

  4. Yao YL, Shao J, Zhang C, Wu JH, Zhang QH, Wang JJ, et al. Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: Erbb2/erbb3/akt and met/erbb3/mapk. PLoS One. 2013;8:e78086.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, et al. Loss of nrdp1 enhances erbb2/erbb3-dependent breast tumor cell growth. Cancer Res. 2006;66:11279–86.

    Article  CAS  PubMed  Google Scholar 

  6. Lu H, Li H, Mao D, Zhu Z, Sun H. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27. Tumour Biol. 2014;35:8639–43.

    Article  CAS  PubMed  Google Scholar 

  7. Jiang Y, Sun S, Liu G, Yan B, Niu J. Nrdp1 inhibits metastasis of colorectal cancer cells by egfr signaling-dependent mmp7 modulation. Tumour Biol. 2015;36:1129–33.

    Article  CAS  PubMed  Google Scholar 

  8. Wang L, Chi YF, Yuan ZT, Zhou WC, Yin PH, Zhang XM, et al. Astragaloside iv inhibits the up-regulation of wnt/beta-catenin signaling in rats with unilateral ureteral obstruction. Cell Physiol Biochem. 2014;33:1316–28.

    Article  CAS  PubMed  Google Scholar 

  9. Di Leva G, Croce CM. Mirna profiling of cancer. Curr Opin Genet Dev. 2013;23:3–11.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of mirna cancer therapeutics. Drug Discov Today. 2013;18:282–9.

    Article  CAS  PubMed  Google Scholar 

  11. Song W, Li Q, Wang L, Wang L. Modulation of foxo1 expression by mir-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem. 2015;35:184–90.

    Article  CAS  PubMed  Google Scholar 

  12. Shen L, Li J, Xu L, Ma J, Li H, Xiao X, et al. Mir-497 induces apoptosis of breast cancer cells by targeting bcl-w. Exp Ther Med. 2012;3:475–80.

    CAS  PubMed  Google Scholar 

  13. Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, et al. Analysis of mir-195 and mir-497 expression, regulation and role in breast cancer. Clin Cancer Res. 2011;17:1722–30.

    Article  CAS  PubMed  Google Scholar 

  14. Wang S, Li H, Wang J, Wang D. Expression of microrna-497 and its prognostic significance in human breast cancer. Diagn Pathol. 2013;8:172.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Luo Q, Li X, Gao Y, Long Y, Chen L, Huang Y, et al. Mirna-497 regulates cell growth and invasion by targeting cyclin e1 in breast cancer. Cancer Cell Int. 2013;13:95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. von Kleist S, Chany E, Burtin P, King M, Fogh J. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst. 1975;55:555–60.

    Article  Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaochuan Sun.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

An erratum to this article is available at http://dx.doi.org/10.1007/s13277-017-5487-6.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, Y., Meng, Q., Qi, J. et al. RETRACTED ARTICLE: MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition. Tumor Biol. 36, 7641–7647 (2015). https://doi.org/10.1007/s13277-015-3489-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3489-9

Keywords